SynthesisFrontiers in oncology2022

Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma: A meta-analysis.

Jia Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.